| Document |
Document Title |
|
WO/2015/028938A1 |
The invention relates to naphthalene compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated wi...
|
|
WO/2015/028193A1 |
This invention relates to an etheramine of formula (I) based on glycerine or trimethylolpropane and its manufacturing process, wherein R = H or ethyl, k = 0 or 1 A represents a linear or branched alkylene group having C2-C18 carbon atoms...
|
|
WO/2015/022631A1 |
The invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modul...
|
|
WO/2015/017906A1 |
The present invention relates to diphenyloxyalkylamine derivatives and aryloxyalkylamine derivatives that are structurally analogous to mexiletine, said derivatives having important biological activity and not causing the undesired side ...
|
|
WO/2015/020545A2 |
The invention discloses new derivatives of N-[(phenoxy)ethoxy]alkylaminoalkanols with the structure which show pharmacological activity, especially in therapy and/or prophylaxis disorders and/or symptoms withneurological etiology.
|
|
WO/2015/014816A1 |
The invention refers to compounds of general formula (I) wherein the variables take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly in pain therapy.
|
|
WO/2014/202765A1 |
The present invention provides an asymmetric and economic synthesis of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H-benzo[d]azepine via novel intermediates applying an asymmetric enzymatic, biomimetic or catalytic reduction. The present inve...
|
|
WO/2014/200094A1 |
[Problem] To provide a novel production method for a stereoselective, optically active alcohol compound. [Solution] From the compound represented by formula (3), the optically active alcohol compound represented by formula (8) can be pro...
|
|
WO/2014/198880A1 |
The invention provides a compound of formula (I) wherein R2-R10 represent different meanings, and pharmaceutically acceptable salts thereof. The invention also provides synthetic procedures for preparing the compounds of formula (I), pha...
|
|
WO/2014/197991A1 |
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...
|
|
WO/2014/181533A1 |
A compound that increases the photocuring rate of a photocurable composition and reduces the force for releasing a cured product from a mold is provided. A compound is represented by general formula (1): where Rf represents an alkyl grou...
|
|
WO/2014/175267A1 |
The purpose of the invention is to provide a novel organometallic compound that can be utilized as a catalyst having high generality, high activity, and excellent functional group selectivity. The invention pertains to a novel organometa...
|
|
WO/2014/176421A1 |
Provided herein are, inter alia, compositions including a surfactant and a novel compound useful in enhanced oil recovery. The compositions and methods provided herein may be particularly useful for oil recovery under a broad range of re...
|
|
WO/2014/176424A1 |
Provided herein are, inter alia, heavy crude oil emulsion compositions and methods of making the same. The compositions and methods provided herein are particularly useful for the transport of heavy crude oils.
|
|
WO/2014/169847A1 |
The present invention provides,among others,compounds of Formula (I)or a salt thereof,methods for making these compounds,degradable polymers and reinforced composites made therefrom,and methods for degrading and/or recycling the degradab...
|
|
WO/2014/154783A1 |
This invention relates to polyetheramines based on 1,3-dialcohols, in particular to an etheramine mixture comprising at least 90% by weight, based on the total weight of the etheramine mixture, of anamine of Formula (I) and/or (II), wher...
|
|
WO/2014/136086A1 |
This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1–R4, L and X are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic li...
|
|
WO/2014/133014A1 |
Provided is a mononuclear ruthenium complex that comprises a ruthenium-silicon bond that is represented by formula (1) and that exhibits excellent catalyst activity in each of a hydrosilylation reaction, a hydrogenation reaction, and red...
|
|
WO/2014/133017A1 |
Provided is a mononuclear iron complex that comprises an iron-silicon bond that is represented by formula (1) and that exhibits excellent catalyst activity in each of a hydrosilylation reaction, a hydrogenation reaction, and reduction of...
|
|
WO/2014/128198A1 |
The invention relates to bilaterally-substituted tricyclic compounds and pharmaceutical compositions containing them, for use as medicaments. Due to their ability to interact with an internal RNA loop and to mimic a protein a-helix these...
|
|
WO/2014/124013A1 |
The present invention relates to amino diol derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
|
|
WO/2014/120907A1 |
Disclosed herein are scavenging compounds and compositions useful in applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also disclosed herein are methods of using the compounds ...
|
|
WO/2014/112646A1 |
The present invention addresses the problem of providing a compound having a selective inhibitory activity on LAT-1 that can be expressed in a tumor cell at a high level. The present invention provides: a compound represented by formula ...
|
|
WO/2014/111980A1 |
The present invention provides: a Janus-type triptycene derivative which is represented by general formula [I] and is useful as a material for a self-assembled monomolecular film; a Janus-type triptycene derivative which is represented b...
|
|
WO/2014/101460A1 |
Disclosed are a preparation method of a functionalized choline chloride ionic liquid shown in formula I, and use thereof in an electrochemical energy storage device, as an electrolyte material or an additive used in a lithium ion battery...
|
|
WO/2014/100591A1 |
This disclosure relates to methods for limiting the undesired reverse Mannich reaction during the hydrogenation reduction of one or more nitro functional groups (-NO2) to their corresponding amines (-NH2).
|
|
WO/2014/096377A1 |
New hydroxy aliphatic substituted phenyl aminoalkyi ether compounds of formula (I), compositions thereof and their use as a medicament in the treatment of nervous system diseases and/or the treatment of developmental, behavioral and/or m...
|
|
WO/2014/090642A1 |
The present invention relates to a composition comprising a pesticide and an alkoxylate. The invention further relates to the alkoxylate, to a method for the production thereof and to the use there of as adjuvant in pesticide-comprising ...
|
|
WO/2014/091020A1 |
The present invention refers to phenanthrene derivatives for use as medicaments, in the prevention and/or treatment of Myotonic Dystrophy Type 1, Huntington's Disease Like 2, Spinocerebellar Ataxia Type 8, Myotonic Dystrophy Type 2, Spin...
|
|
WO/2014/082871A1 |
The present invention relates to substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds of formula (I) as defined in the description, and the N-oxides, and salts thereof, their preparation and intermediates for preparing ...
|
|
WO/2014/082880A1 |
The present invention relates to substituted [1,2,4] triazol compounds of the formula I wherein the substituents are defined in the claims and the description, and the N-oxides and the salts thereof for combating phytopathogenic fungi, a...
|
|
WO/2014/082879A1 |
The present invention relates to substituted [1,2,4]triazol compounds of formula (I) wherein the substituents are described in the claims and the description, and the N-oxides and the salts thereof for combating phytopathogenic fungi, an...
|
|
WO/2014/082872A1 |
The present invention relates to substituted [1,2,4]triazol compounds of formula (I), wherein the substituents are defined in the claims and the description, and the N-oxides and the salts thereof for combating phytopathogenic fungi, and...
|
|
WO/2014/082881A1 |
The present invention relates to substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds of formula I as defined in the description,and the N-oxides, and salts thereof, their preparation and intermediates for preparing the...
|
|
WO/2014/074778A1 |
The present invention relates to the antimalarial compounds of formula (l)and their use against protozoa of the genus Plasmodium, including drug-resistant Plasmodia strains. This invention further relates to compositions containing such ...
|
|
WO/2014/000629A9 |
The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in g...
|
|
WO/2014/067767A1 |
The invention is directed to ruthenium-based metathesis catalysts of the Grubbs-Hoveyda type. The new 2-aryloxy-substituted ruthenium catalysts described herein reveal rapid initiation behavior. Further, the corresponding styrene-based p...
|
|
WO/2014/069555A1 |
Provided is a compound that exhibits an excellent melanogenesis-inhibiting effect (skin-lightening effect), exhibits an excellent antimicrobial effect, excels in terms of temporal stability and the like, and is suitable for use as an ing...
|
|
WO/2014/066361A1 |
The composition of the present invention related to a quaternary ammonium salt detergent and the use of such quaternary ammonium salt detergents in a fuel composition to reduce diesel injector deposits and remove or clean up existing dep...
|
|
WO/2014/066713A1 |
A process has been developed for preparing 2-methoxymethyl-1,4-benzenediamine (IV-a), other compounds of formula (IV), and the salts thereof, all of which may be used as primary intermediates in compositions for dyeing keratin fibers.
|
|
WO/2014/066712A1 |
A process has been developed for preparing 2-methoxymethyl-1,4-benzenediamine (IV-a), other compounds of formula (IV), and the salts thereof, all of which may be used as primary intermediates in compositions for dyeing keratin fibers.
|
|
WO/2014/065122A1 |
An aniline compound such as aniline, 2,3-difluoroaniline, or 3-fluoroaniline; and a halo-oxirane compound such as 2-chloro-2-(diethoxymethyl)-3-methyloxirane and the like are caused to react in the presence of a base such as sodium bicar...
|
|
WO/2014/066344A1 |
The composition of the present invention related to a quaternary ammonium salt detergent and the use of such quaternary ammonium salt detergents in a fuel composition to reduce diesel injector deposits and remove or clean up existing dep...
|
|
WO/2014/056421A1 |
Provided are a 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound, and preparation method and use thereof in the preparation of agomelatine intermediate 2-(7-methoxyl-1-naphtyl) ethylamine. Also provided is an agomelatine preparatio...
|
|
WO/2014/056886A1 |
The present invention relates to electrochemical and optoelectronic devices comprising a cobalt complex operatively connected to a dye-sensitizer comprising at least one thiophene moiety. Also, novel dye-sensitizers, methods of making th...
|
|
WO/2014/054391A1 |
A compound represented by general formula (1). In general formula (1), R1 represents either one of a protective group for a hydroxy group and a hydrogen atom, and R2 and R3 independently represent a protective group for an amino group.
|
|
WO/2014/047099A1 |
Described are dye fixative agents, comprising an ether compound, including salts, of Formula I: wherein, R1 is, independently at each occurrence, C1-C6 alkyl; R2 and R3, are, independently at each occurrence, optionally substituted C6 al...
|
|
WO/2014/031874A1 |
The present invention relates to particular phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering biologically active agents to a target. These compounds are well suited for forming non-covalent mixtures with activ...
|
|
WO/2014/026952A1 |
The invention relates to a meta-phenylenediamine compound of formula (I) below, the addition salts thereof with an acid and the solvates thereof: in which: R represents a hydrogen or halogen atom; a C1-C4 alkyl radical; a carboxyl radica...
|
|
WO/2014/024205A1 |
The present invention is in relation to a method for preparation of (S)-(+)-N, N-dimethyl-[3-(naphthalen-1-yloxy)-1-phenylpropyl]amine or its pharmaceutically acceptable salt and intermediate thereof. The method is industrially viable, e...
|
